Vitamin D Supplementation in PCOS Patients

Tanta University170 enrolled

Overview

To assess whether Vitamin D supplementations for patients with polycystic ovary syndrome in conjunction with clomiphene citrate are beneficial or not

This study is double blinded randomized controlled study conducted at Tanta University hospitals in the period from April 2019 to March 2022. Patients and methods: One hundred twelve patients were recruited and randomly allocated into 2 groups; study group with Vitamin D supplementation and control group without Vitamin D supplementation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

170

Conditions

PCOS

Interventions

Vitamin DDRUG

receive 6000iu daily for 8 weeks

Placebo Oral TabletDRUG

placebo for the same period

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 35 Years

Medical Language ↔ Plain English

Inclusion Criteria: * PCOS * Infertile * Vitamin D deficient Exclusion Criteria: * Age less than 20 and more than 35 * Non PCOS patients * Obese patients * Previous ovarian surgery * Previous oophrectomy of one ovary

Locations (1)

Ayman Shehata Dawood

Tanta, Algharbia, Egypt

Outcomes

Primary Outcomes

Ovulation rate

Number of mature follicles obtained

Time frame: 3 months

Pregnancy rate

Number of patients who get pregnant

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.